Plasticell Spins Out Regenerative Drug Discovery Venture

New demerged business called ‘Progenitor Labs’ Plasticell Ltd, the biotechnology company developing high throughput stem cell technologies, has announced today that following its recent £3.5m financing, it has undergone a strategic re-structuring to enable the Company to focus on its award winning CombiCult™ technology for stem cell differentiation. Consequently, Plasticell Ltd has demerged its regenerative drug discovery unit into a [...]

April 13th, 2011|Press Releases|

Plasticell completes £3.5 million financing round

Capital injection to expand business development and marketing initiatives Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced it has completed a two-part equity financing, raising a total of £3.5 million from new and existing investors. The first tranche of the financing, in which £1.5 million was drawn down in April 2009, was [...]

January 31st, 2011|Press Releases|

Plasticell signs technology agreement with Sigma-Aldrich

Collaboration to produce novel turnkey solution for stem cell research Plasticell, the biotechnology company specialising in high throughput technologies for directed stem cell differentiation, has announced the signing of a collaboration agreement with Sigma-Aldrich, a leading provider of technologies and reagents to the life science research market. In the collaboration, Sigma-Aldrich will use its CompoZr® Zinc Finger Nuclease Technology to [...]

November 29th, 2010|Press Releases|

Plasticell signs screening collaboration with UCB. First in kind deal to partner small molecule drugs for stem cell research

Plasticell, the biotechnology company specialising in the use of innovative high throughput technologies in stem cell research, has announced signing of a collaboration agreement with the biopharmaceutical company, UCB. Under the terms of the agreement, UCB will supply Plasticell with drug compound libraries with known biological targets. Plasticell will screen these using its award-winning CombiCult technology to discover new cell [...]

November 8th, 2010|Press Releases|

Plasticell validates regenerative drug screen in collaboration with GSK

London, 12 March 2009 … Research announced today by Plasticell, a leading UK regenerative medicine biotech company, shows how embryonic stem cells can be used to discover novel small molecules capable of encouraging the body to regenerate, potentially paving the way for the development of drugs to repair organs damaged by disease or ageing. Plasticell used its proprietary technologies to [...]

March 12th, 2009|Press Releases|

Plasticell funds two Industrial Collaborations with University College London

London, UK, 15 January 2009. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, today announced that it is funding industrial collaborative projects in two separate laboratories based in University College London (UCL). The first collaboration, with the groups of Professors Chris Mason and Nigel Titchener-Hooker, of the UCL Advanced Centre for Biochemical Engineering, will result [...]

January 15th, 2009|Press Releases|

Plasticell obtains investment from TSB Technology Programme

London, UK, 1 October 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced it has received further funding from the Technology Strategy Board (TSB; formerly part of DTI) to apply its technologies towards developing a novel cell therapy designed to stimulate and sustain tissue regeneration. Plasticell is part of a consortium, additionally comprising [...]

October 1st, 2008|Press Releases|

Plasticell publication describes combinatorial methods in stem cell research

London, UK, 1 August 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced the publication of a book chapter which presents the case for combinatorial methods in stem cell research. The chapter by Dr. Yen Choo, Plasticell’s founder, is entitled ‘Use of Combinatorial Screening to Discover Protocols That Effectively Direct the Differentiation of [...]

August 1st, 2008|Press Releases|

Plasticell appoints Professor Tony Cass to the Scientific Advisory Board

London, UK, 2 April 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has appointed Professor Tony Cass to its Scientific Advisory Board. Professor Cass is Professor of Chemical Biology, Deputy Director and Bio-nanotechnology Research Director in the Institute of Biomedical Engineering at Imperial College London. He is also a Founder and Executive Director of [...]

April 2nd, 2008|Press Releases|

Plasticell acquires rights to two further human embryonic stem cell lines from King’s College London

London, UK, 13 February 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with King’s College London (London, UK) to exploit and market two human embryonic stem cell (hESC) lines. hESC lines are specialized cells capable of forming all tissues of the body, and are thus a source of human [...]

February 13th, 2008|Press Releases|

Plasticell acquires rights to six human embryonic stem cell lines

London, UK, 14 January 2008. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with Axordia Ltd (Sheffield, UK) to exploit and market a panel of six human embryonic stem cell (hESC) lines. hESC lines are specialized cells capable of forming all tissues of the body, and are thus a source [...]

January 14th, 2008|Press Releases|

Plasticell Chief Executive appointed to the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines

London, UK, 13 November 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has announced that Dr Yen Choo, the company’s Chief Executive, has been appointed to the Steering Committee for the UK Stem Cell Bank and for the Use of Stem Cell Lines. Dr Choo is the first member of the Committee recruited from [...]

November 13th, 2007|Press Releases|

Sir Martin awarded Nobel Prize for pioneering stem cell research.

London, UK, 9 October 2007. Plasticell Ltd is delighted to note that Sir Martin Evans, a founding member of the company’s Scientific Advisory Board, has been awarded this year’s Nobel Prize in Physiology or Medicine together with Mario Capecchi and Oliver Smithies for their discoveries of "principles for introducing specific gene modifications in mice by the use of embryonic stem [...]

October 9th, 2007|Press Releases|

Plasticell and Hamilton Company announce agreement to automate high throughput stem cell differentiation technology

London, UK, 24 September 2007. Plasticell, the biotechnology company developing regenerative drugs using high throughput stem cell technologies, has entered into an agreement with Hamilton Company, a worldwide leader in robotic liquid handling devices and laboratory automation, to automate Plasticell’s Combinatorial Cell Culture™ technology for the determination of optimal protocols to direct stem cell differentiation. Plasticell and Hamilton will develop [...]

September 24th, 2007|Press Releases|

Plasticell to develop stem cell robotics with £1.1m funding from DTI

London, UK, 25 January 2007. Plasticell Ltd, the UK biotechnology company developing drugs to regenerate tissues of the body, announced today that it has secured a £1.1m Technology Programme grant from the Department of Trade & Industry (DTI), to support a three year collaborative research and development project entitled “A technology to ensure optimum cell performance for regenerative medicine”. Plasticell [...]

January 25th, 2007|Press Releases|

Plasticell Relocates to Imperial BioIncubator

London, UK, 2 Jan 2007. Plasticell Ltd, the UK biotechnology company developing drugs to regenerate tissues of the body, has relocated its offices and laboratories to the newly opened Imperial BioIncubator, a facility managed by Imperial Innovations and sited at Imperial College London’s South Kensington campus. Plasticell is the first external company to be admitted to the BioIncubator and joins [...]

January 2nd, 2007|Press Releases|